Dubai, UAE
PO BOX: 926510
TRN: 104277403200003
We are pleased to inform you that we have successfully completed Milestone 2 (M2) and Milestone 3 (M3) for the NeuroSense360 MVP - AML Compliance Platform project, as per Purchase Order PUR-ORD-2025-00013.
Both milestones were completed on 10 January 2026 and have been thoroughly tested and deployed to production. The platform is now feature-complete with full backend infrastructure, comprehensive frontend interface, and end-to-end AML screening capabilities.
✓ Milestone 2 (M2) - Core Platform Development (₹55,000)
- Backend API Infrastructure: Complete RESTful API architecture with authentication and authorization
- Database Schema: Comprehensive AML-specific data models with relationships and indexing
- Core Screening Engine: Integration with AML screening algorithms and risk scoring
- User Management: Role-based access control (RBAC) with admin, analyst, and viewer roles
- API Documentation: Complete Swagger/OpenAPI documentation with testing endpoints
✓ Milestone 3 (M3) - Frontend & Integration (₹82,500)
- Responsive Frontend UI: Modern, intuitive interface built with React and TypeScript
- Real-time Dashboard: Live screening results with status indicators and alerts
- Case Management Interface: Comprehensive workflow for reviewing and managing AML cases
- External Data Integration: Connection to external AML databases and watchlists
- Reporting & Export: Customizable reports with PDF and CSV export functionality
- End-to-End Testing: Comprehensive QA testing and bug resolution
- Production Deployment: Successful deployment and handover with documentation
Project Payment Status:
| Milestone | Percentage | Amount | Status |
|---|---|---|---|
| M1 - Advance Payment | 40% | ₹110,000.00 | ✓ Paid (20 Nov 2025) |
| M2 - Core Platform | 20% | ₹55,000.00 | 📄 Current Invoice |
| M3 - Frontend & Integration | 30% | ₹82,500.00 | 📄 Current Invoice |
| M4 - Final Acceptance | 10% | ₹27,500.00 | ⏳ Pending UAT |
| Total PO Value | ₹275,000.00 | ||
Current Invoice Summary:
(One Lakh Thirty-Seven Thousand Five Hundred Indian Rupees Only)
Bank Transfer Details:
The NeuroSense360 platform is now fully operational with all core features implemented and tested. The system successfully performs AML screening, manages cases, generates comprehensive reports, and integrates with external data sources as specified in the requirements.
Technical Highlights: The platform has been built with industry best practices for security, performance, and scalability. All sensitive data is encrypted, API endpoints are secured with JWT authentication, and the frontend provides an intuitive user experience for compliance teams.
Next Steps: We are now ready to proceed with Milestone 4 (M4) - Final User Acceptance Testing and sign-off. Upon successful completion of UAT and final acceptance, the remaining 10% (₹27,500) will be invoiced as per the project agreement.
We appreciate the continued collaboration with Bettroi FZE on this important AML compliance initiative. The platform is ready for comprehensive user acceptance testing, and we remain available for any support, training, or clarifications required.
Please review the completed milestones and process the payment at your earliest convenience. We look forward to successfully concluding the project with Milestone 4.
Best Regards,
Mobile: +91 93731 11709
Website: www.drmhope.com